EUVIMEDEUVIMED entdecken
Open Access

Barriers to WHO prequalification of similar biotherapeutic insulin

Henry Mj Leng, Jicui Dong

Bulletin of the World Health Organization · 2024

DOI: 10.2471/blt.24.291804 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bulletin of the World Health Organization, 2024. Verfasst von Henry Mj Leng und 1 weiteren Autor:innen. Beteiligte Einrichtung: Innovation and Emerging Technologies Department, Access to Medicines and Health Products Division, World Health Organization, 20 Avenue Appia, 1211Ge…. Hauptthemen laut MEDLINE: World Health Organization, Drug Industry, Insulin. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: World Health Organization.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

World Health OrganizationDrug IndustryInsulinHumansSurveys and QuestionnairesDrug ApprovalBiosimilar Pharmaceuticals

Substanzen

InsulinBiosimilar Pharmaceuticals

Autor:innen und Institutionen

  • Innovation and Emerging Technologies Department, Access to Medicines and Health Products Division, World Health Organization, 20 Avenue Appia, 1211Geneva, Switzerland.

Förderung

  • World Health Organization

Zitieren

APA

Leng, H. M., & Dong, J. (2024). Barriers to WHO prequalification of similar biotherapeutic insulin. Bulletin of the World Health Organization. https://doi.org/10.2471/blt.24.291804

Vancouver

Leng HM, Dong J. Barriers to WHO prequalification of similar biotherapeutic insulin. Bulletin of the World Health Organization. 2024. doi:10.2471/blt.24.291804

BibTeX
@article{Leng2024,
  author = {Leng, Henry Mj and Dong, Jicui},
  title = {Barriers to WHO prequalification of similar biotherapeutic insulin},
  journal = {Bulletin of the World Health Organization},
  year = {2024},
  doi = {10.2471/blt.24.291804}
}
Kostenlos starten →